💡 What if tomorrow morning it’s your 142nd patient? 💡
Every successful shock can make a critical difference in patient outcome.
Clinical trials have proven it.
👉 Tomorrow morning, your patient counts on you. What will you choose?
Successful shocks are critical to the life-saving benefits of ICDs, as shown by clinical trials. While most manufacturers' devices provide up to 6 shocks in the VF zone, Boston Scientific ICDs deliver 8. This is crucial, as 1 in 142 patients requires more than 6 shocks to convert VT/VF episodes. Learn more: https://t.co/E7DuaV9Xyh
Safety info: https://t.co/uK1ApEyZY9
@stats_feed I guess the “good for living” variabile is playing a role here: Barcelona, Bordeaux, Stockholm (which i all visited many times) are somewhat overrated imho. Btw score are always biased and consequently subject to criticism 😃.
Does prior sternotomy influence S-ICD functionality? Does CT surgery with pre-existing S-ICD place lead at risk? You might be surprised by what @PennCardiology researchers found through a multi-institutional investigation #AHAJournals#Epeeps https://t.co/lrdhLKSHIu
#BostonScientific è partner principale di Rhythm Interventions Online
✅casi dal vivo
✅presentazioni
✅dibattiti
tra elettrofisiologi di prima linea.
Scopri l'agenda e registrati gratuitamente
Join us at Rhythm Interventions Online https://t.co/WtNZllazf4
Preso appuntamento con una consulente oggi alle 18 presso Ufficio Roma Appio. Della consulente neanche l’ombra. Vergogna! @PosteNews @MISE_GOV@AGCOMunica
Dopo aver preso il biglietto ed atteso un’ora, mi dicono che c’è uno sciopero e che non possono effettuare più operazioni allo sportello via Taranto, Roma.
Bel modo di trattare i clienti. @PosteNews @consumatori@Altroconsumo@MISE_GOV@AGCOMunica
The @loveurheart added #sleep to its list of factors for cardiovascular health. The others are a healthy diet; physical activity; low levels of nicotine exposure; and healthy levels of weight, cholesterol, blood sugar, and blood pressure. #HarvardHealth
https://t.co/hayoIPRLa1
See how FARAPULSE PFA is transforming Afib treatment through tissue-selective ablation via optimised system design, validated workflow, and supported PV lesion durability with ~3-month remapping data to show how acute translates to chronic success: https://t.co/pDstOInrrN
FARAPULSE™ PFA real-world procedural outcomes: Data from two German centers was shared at HRS on 138 AF patients that underwent PVI with the FARAPULSE™ PFA System. See the full study results HERE: https://t.co/yP9vr4r4Kb
How is your heart doing after #Covid-19?
👉 People who had been admitted to intensive care with acute infections had ⬆️ risk of cardiovascular problems during the next year.
❗even people who had not been hospitalized had ⬆️ risks of many conditions
https://t.co/bN6g7pN1Kl
Il primo studio prospettico randomizzato che dimostra le QUALITÀ superiori dell’ #SICD per cui è stato progettato: una riduzione significativa di TUTTE le complicanze “lead related” vs T-ICD a parità di EFFICACIA 💪🏻.
#bostonscientific#suddencardiacdeath#scd#BSC
Implantable defibrillator-detected heart failure status predicts atrial fibrillation occurrence, by @MatteoBertini5 and colleagues https://t.co/4RGM82M7FH